AbstrAct
Background Sudden cardiac death (SCD) is a major global health problem, accounting for up to 20% of deaths in Western societies. Clinical quality registries have been shown in a range of disease conditions to improve clinical management, reduce variation in care and improve outcomes. Aim To identify existing cardiac arrest (CA) and SCD registries, characterising global coverage and methods of data capture and validation. Methods Biomedical and public search engines were searched with the terms 'registry cardio*'; 'sudden cardiac death registry' and 'cardiac arrest registry'. Registries were categorised as either CA, SCD registries or 'other' according to prespecified criteria. SCD registry coordinators were contacted for contemporaneous data regarding registry details. Results Our search strategy identified 49 CA registries, 15 SCD registries and 9 other registries (ie, epistries). Population coverage of contemporary CA and SCD registries is highly variable with registries densely concentrated in North America and Western Europe. Existing SCD registries (n=15) cover a variety of age ranges and subpopulations, with some enrolling surviving patients (n=8) and family members (n=5). Genetic data are collected by nine registries, with the majority of these (n=7) offering indefinite storage in a biorepository. Conclusions Many CA registries exist globally, although with inequitable population coverage. Comprehensive multisource surveillance SCD registries are fewer in number and more challenging to design and maintain. Challenges identified include maximising case identification and case verification. Trial registration number CRD42019118910.
InTRoduCTIon
Sudden cardiac death (SCD) is a major global public health issue, accounting for up to 20% of deaths in Western societies. 1 The WHO defines SCD as a sudden unexpected death within 1 hour of symptom onset or within 24 hours of having been last seen well. 1 For patients aged under 35 years old, no cause is identified in up to 30% of cases after forensic analysis. 2 Unexplained SCD is frequently associated with devastating psychological and economic impact on both the family and community. Furthermore, genetic relatives may inherit conditions associated with SCD risk that requires characterisation and management.
A clinical quality registry is an organised system using prospective observational study methods to collect data to evaluate specific outcomes for a population. 3 Well-designed registries are cost-effective, typically delivering approximately a 4:1 return on investment. 4 Cardiac arrest (CA) and SCD registries have been shown internationally to assist epidemiological analysis and improve care linkage between hospital, forensic and ambulance services. Additionally, SCD registries provide ongoing clinical care and may help
Key questions
What is already known about this subject?
► Many cardiac arrest and sudden cardiac death registries have been established around the world. This is a comprehensive review using geographic mapping to provide a contemporary picture of the sudden cardiac death registry landscape.
What does this study add?
► This study provides a resource of existing registries, highlights areas of geographic inequity, and compares international metrics of sudden cardiac death identification and adjudication. It identifies unique challenges in registry design that merit further discussion.
How might this impact on clinical practice?
► Clinical registries are now recognised to deliver clinical benefits. initiate critical testing for survivors and family members of SCD victims. 5 We sought to provide a comprehensive description and analysis of current global resources dedicated to CA and SCD registries, in the context of designing Australia's first multisource surveillance SCD registry, the Unexplained Cardiac Death Project (UCDP Registry). Key aims were to identify reported challenges experienced by other registries, design data collection to maximise clinical utility and novelty and identify gaps in existing population coverage.
MeTHods search strategy
Identification of current CA and SCD registries was performed via PubMed search (search terms=registry cardio*, registry+sudden+cardiac+death, cardiac+ar-rest+registry, search filter=Title/Abstract for all searches, results=1395+448+1328, respectively, as of 10 December 2018), citation tracking and interrogation of the internet search engine Google for registries with public websites or published annual reports. A separate search was also conducted in Google using the search term 'cardiac+ar-rest+registry+country', with 'country' being each of the recorded member countries of the United Nations (figure 1). All searches were performed in the English language. The search strategy was performed by two authors (EDP and LR) independently, then results were compared. Discrepancies were discussed and resolved between authors, with referral to a third author for adjudication if required. All coauthors on this publication were requested to further nominate any registries recognised as being missed by the search strategy. The search strategy and review structure were preregistered with PROSPERO as a systematic review.
Inclusion/exclusion criteria and characterisation of registries
Only registries collecting data prospectively were considered for inclusion. We included national registries or the four largest state registries for analysis. Exclusion criteria included retrospective data analysis or inactivity for more than 10 years. Genetic heart disease registries (eg, long QT syndrome registries and hypertrophic cardiomyopathy registries) were also excluded, as the majority of these registries enrol living patients and primarily evaluate diseasespecific management rather than CA outcomes.
Registries were categorised as CA registries if they primarily evaluated resuscitation outcomes using Utstein style templates. 6 Registries were required to appear independently in search results (not only as part of a referring data source to a higher level epistry) and have issued either research publications or an annual report of clinical volume to qualify for inclusion.
Registries were categorised as SCD clinical quality registries if they used more than one data source (ie, ambulance and forensic data) to validate SCD case reporting and undertook ongoing data collection and clinical follow-up. 7 Registries collecting data relating to SCD not meeting the above criteria were categorised as 'other'. Registries categorised as 'other' included higher level epidemiological registries or 'epistries' collecting a minimum data set of CA variables from participating smaller registries, intermittent collection registries collecting snapshot data periodically, large-scale 'deep-phenotyping' registries archiving genetic data of patients only without any clinical correlation or clinical care provided and registries limited to single centres.
As this is a systematic review of existing CA and SCD registries, patient/public involvement was not feasible.
outcomes assessed
We compiled a list of all existing CA, SCD and 'other' registries, with geographic mapping to identify areas of global under-representation. CA, cardiac arrest; FIFA-SDR, federation internationale de football association -sudden death registry; OHCA, out of hospital cardiac arrest; SCD, sudden cardiac death; SCDY, sudden cardiac death in the young.
Figure2 Current global distribution of cardiac arrest, sudden cardiac death and other registries.
Listed coordinators of SCD registries were individually contacted to confirm details of case identification and obtain contemporary enrolment numbers. We identified age groups enrolled, type of patient group enrolled (deceased, survivors and/or family members) and reported strategies for genetic material collection and storage.
From methodology published by existing SCD registries, we also derived a table of potential data sources that may be employed for multisource surveillance when creating an SCD registry. We incorporated consideration of published experiences, with particular awareness of real-world implementation difficulties acknowledged by registry leaders.
ResulTs
We identified 49 CA registries and 15 SCD registries, including the newly formed Australian UCDP Registry [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] (table 1). Nine registries were categorised as 'other'. The global population coverage of registries is patchy, with the majority being densely located in Western Europe and North America (figure 2). There were no CA or SCD registries identified in any of Russia, India or China, and no out-of-hospital CA or SCD registries identified in South America. There are currently no active registries in Africa.
CA registries
Forty-nine CA registries were identified using the predefined search strategy. Within low-income or middleincome countries, the Egypt Cardiac Arrest Project was the only identified independent registry; however, multiple other low-income or middle-income countries contribute data to the Pan-Asian Resuscitation Outcomes Study (PAROS), a higher level epistry. Forty-five registries (91.8%) function predominantly as out-of-hospital CA registries, with the Get With the Guidelines Registry, UK National Cardiac Arrest Audit, Danish In-hospital Cardiac Arrest Registry and Brazilian CODE registry collecting exclusively in-hospital CA data. 18 There Several registries enrol only specified subgroups experiencing SCD: for example, two registries (SCD Germany and FIFA-SDR) recruit only SCDs during competitive sport. Elsewhere, the North American Sudden Death in the Young Registry (SDY) and Sudden Unexplained Death in Childhood (SUDC) registries are exclusively for paediatric patients, while four other registries (PanAfrica SCD, Douala-SCD, Tunisian SCD and SUDDEN) enrol adult cases (>15 years old) only.
All registries capture basic clinical and demographic information. Eight registries (53.3%) explicitly state mechanisms to identify and enrol sudden cardiac arrest (SCA) survivors, and five (33.3%) enrol family members of SCD patients, with varying degrees of inclusion and screening. Nine registries (60.0%) perform genetic analysis on enrolled patients. Of these, seven (46.6%) collect and store specimens in a biorepository with the potential for future return of clinically important analyses such as new diagnoses made in the context of new discoveries in cardiac genetics.
The registries use multiple data surveillance techniques to refine data collection (figure 3). From described methods and experiences, potential data sources are presented in table 3. Four registries (26.7%) rely primarily on ambulance-based referrals, four (26.7%) on forensic referrals and seven (46.6%) on medical practitioner and family referrals. The majority of registries use all these sources of referral with varying emphasis. Seven registries (Unexplained Cardiac Death Project, SDY, SUDC, Cardiac Risk in the Young, Oregon SUDS, SCD Germany 
Commencing from 2018
LVEF, left ventricular ejection fraction; SCA, sudden cardiac arrest; SCD, sudden cardiac death; VF, ventricular fibrillation; VT, ventricular tachycardia. Table 2 Continued Figure 3 Multi-source data surveillance and capture provides the optimum mechanism of case adjudication and refining case inclusion in SCD registries.
and FIFA-SDR) also have publicly accessible websites explaining registry structure and recruitment methods, with referral options for medical practitioners and families to nominate cases of SCD.
dIsCussIon Our review identifies that there are many existing CA registries operating in the developed world. Ideally, CA registries can function both as stand-alone large registries of prehospital data and also collaborate as major data sources for a local SCD registry. When creating a SCD registry, we have identified three primary challenges with regards to data capture. These are comprehensive case capture, case adjudication to assess the true burden of SCD and 'close the loop' on SCD diagnosis for referring CA registries and the ongoing challenge of achieving equitable global coverage.
optimising case capture into existing sCd registries Maximising data inclusion For characterisation of SCD on a population level, maximal case capture is key. There are multiple potential sources of data (table 3) , and integrating multisource data is a key distinguishing feature of SCD registries compared with CA registries.
Although ambulance-reported data are an important source for identifying OHCA cases, not all SCD patients are transported by ambulance for a variety of reasons. For example, patients may be found clearly deceased and transported directly to coronial services. More unusually, availability of ambulance services in some areas of the world may mean that even active CAs are not always transported to hospital by ambulance, as in the Douala-SCD registry where 67% of CA patients arrived at hospital via private taxi cab. 21 The option of capturing all SCDs via postmortem examination is attractive due to the specificity of the SCD diagnosis, and postmortem data have been employed in several major studies as a primary method of data There are over 1300 public and private hospitals in Australia. 42 Contacting each hospital and arranging ethical approval for release on in-hospital audits will be prohibitive.
The registry will be an OHCA registry only. The impact of this is discussed further in the article.
Forensic institutes: autopsy data
Autopsy is the gold standard investigation in verifying that a sudden death is cardiac in aetiology.
Rates of autopsy are falling. 37 Autopsyfocused registries will capture only a subset of total sudden cardiac deaths.
Will be used to verify rates of sudden cardiac death and crossreference with ambulance data.
Death certificate tracking
Should represent the broadest way of capturing the denominator as the endpoint.
Reported rates of death due to 'sudden cardiac death', 'cardiac arrest' and 'heart failure' are notoriously high: the positive predictive value of a death certificate stating 'sudden cardiac death' is only 19%.
26
Needs to be correlated against autopsy data as part of a multiple source surveillance protocol to reduce over-reporting.
Genetic heart disease registries or disease-specific registries (ie, Brugada syndrome)
There will be overlap between patients with genetic heart conditions (and their families) and sudden cardiac death.
Patients already known to have genetic heart disease and enrolled with disease-specific registries will receive appropriate therapy/devices and be anticipated to have a low rate of sudden cardiac death.
Primary utility may be in data linkage or dual referral to both UCDP Registry and disease-specific registry when a death occurs and culprit is identified.
UCDP, Unexplained Cardiac Death Project.
capture. 22 However, in some regions, there are significant cultural barriers to gaining consent for postmortem. 16 Additionally, while postmortem examination is strongly recommended in all SCD victims aged under 40 years old, rates of postmortem examination are reduced in older age groups. 23 Obviously, a postmortem-focused method of recruitment also precludes enrolment of survivors and their families.
Accurate rate reporting Reported rates of OHCA reported around the world vary widely 1 due to a combination of true cultural and genetic variation and discrepancies in the recognition of SCD. Even when strict international criteria are used to define SCD, rates of 'true SCD' show further variation. 24 Limiting data collection to ambulance-reported OHCA is logistically very straightforward and highly appealing. This underpins the function of most CA registries and generates high-quality data that can be used to refine outcomes in the prehospital management of CA.
However, an ambulance-defined SCD does not equate to a true SCD. The WHO definition of an SCD is highly sensitive and thus has the potential to capture many noncardiac causes of death. Tseng and colleagues 25 identified that of 630 out-of-hospital deaths meeting WHO criteria for classification as an SCD, around one in five were identified at autopsy to be due to drug overdose or neurological causes. In Victoria, Australia, 20 a similarly designed study showed even higher rates of misdiagnosis, with 38.6% of WHO-defined SCDs identified to be non-cardiac on subsequent autopsy. Death certificate screening is an even more inaccurate method of identifying cases of SCD, with a positive predictive value of only 19%. 26 It is thus vital to have mechanisms of internal validation within the registry (figure 3), to provide confirmation of definite SCD, and quality control feedback. The majority of multisource SCD registries use an adjudication panel to review cases.
The challenge of equitable global coverage Geographic coverage of existing SCD registries is highly variable. Existing registries are highly concentrated in Western Europe and North America, with low-income and middle-income regions of the world lacking surveillance of SCD. There were no OHCA or SCD registries identified in any of South America, Russia, India or China; together these countries comprise just under half the world's population. In Africa, the Pan-Africa SCD study is still awaiting funding in order to be able to commence, the Douala-SCD registry was ceased after 1 year of recruitment due to financial issues and logistic challenges with patient recruitment (personal communication) and the Tunisian-SCD registry has closed. 27 Under-representation of low-income and middleincome countries is important for several reasons. Preliminary reports suggest that patterns of SCD and their management may vary with geography and ethnicity. From several Asian CA registries, 19 28 29 it would appear that Asian countries may have lower rates of VT/VF as presenting rhythm in OHCA and lower rates of survival to hospital discharge. 28 The Douala-SCD registry reported that there were no survivors of OHCA during the entire recruitment period, reflecting the challenges of CA management in low-resource settings. Although 86.2% of OHCAs were witnessed, cardiopulmonary resuscitation by bystanders was provided in only 7.4% of cases. 30 Although well-designed clinical registries deliver benefits in care and a positive return on financial investment, 4 initial costs may be preclusive for many poorer national health systems. Additionally, the need for specialist expertise to make an accurate diagnosis of SCD (ie, specialist cardiac investigations periarrest and autopsy performed by a qualified specialist postmortem) may be impractical. In Cuba, for example, SCD has been recognised to be grossly under-reported due to confusion around the WHO definition of SCD. 31 Strategies to improve representation of low-income and middle-income countries in SCD registries include training of community health workers with questionnaires to facilitate performance of a 'verbal autopsy' where specialist facilities are not available. 32 33 Automated case identification tools have also been trialled in a range of disease conditions, but currently have only moderate sensitivity in identifying deaths as 'cardiac', let alone any specific cause of SCD or case adjudication. 34 Low-income and middle-income countries contain the bulk of the world's population, and their residents carry an increasing burden of cardiovascular risk factors placing them at risk of SCD. 35 Preliminary data suggest that the majority of SCD is occurring in regions without SCD registries, accurate methods of codifying cause of death and very poor clinical outcomes. 35 Further capturing this information and undertaking quantitative analysis to drive advocacy is essential.
limitations
The search strategy used the English language only, and thus may not have captured registries that have been published on only in non-English languages. Geolocation of the researchers may also have impacted search strategy results compared with results that would be obtained elsewhere in the world. Response from SCD registry coordinators was incomplete.
ConClusIon
Constructing a multisource surveillance SCD registry including data from existing CA registries provides comprehensive care likely to benefit patients and their families, as well as a crucial research platform for the comprehension of true incidence and aetiology of CA. However, existing CA and SCD registries are highly concentrated in developed countries, and case enrolment and verification are challenging. There is scope to learn from existing registry designs to maximise clinical utility. Furthermore, given the recent advances in genetic causes of SCD, collection and storage of biospecimens may be considered a priority.
